European drugs authority EMA takes decision
Final decision due in days
Not sure it needs to be Omicron-specific
Spikevax gets biologics license application (BLA)
Share price up
Mix-and-match offers better immune response
Vaccine efficiency drops to 87% after five months
Particularly against severe COVID symptoms
Not for everyone, though
Belgian study finds
To ensure increased vaccine supply in the EU
Skin rash, two kidney disorders being studied by EMA
All current vaccines effective against Delta variant
Different from the first two
No antibodies found in one in four people above 60
Sacrificing stronger protection, immunity card
Vaccines for 1 mn people received so far
Order now totals 310 million doses
Inoculation campaign underway in Hungary with four approved vaccines
24 cases of British COVID mutation found in Hungary so far
